Atomera (ATOM) Q3 2026 earnings review
Atomera adds chip partners, but revenue drops back to zero
Atomera signed a wafer manufacturing partner and added a third advanced-logic customer, while its quarterly revenue dropped back to zero. The semiconductor technology licensor booked no sales in the third quarter, down from $158,000 in the second quarter, and ended September with zero deferred revenue. Chief executive Scott Bibaud announced a joint development deal with wafer supplier IQE and a third gate-all-around chipmaker in testing, while cash fell by $3.5 million to $34.8 million.
| Revenue | $0 $158K last quarter and $11K a year ago |
|---|---|
| Operating expenses, excluding one-offs | $4.57M +6% from a year ago, -11% from last quarter |
| Cash and short-term investments | $34.8M -$3.5M from last quarter |
| Gate-all-around customers | 3 of 4 up from 2 of 4 last quarter |
⚖️ Verdict: ⚪ Neutral
The story is unchanged because new technical partnerships again arrived without commercial revenue or customer prepayments. Adding IQE to manufacture gallium nitride wafers and bringing in a third gate-all-around evaluator strengthen the technology pipeline. The bad news: total operating lease liabilities more than doubled to $2.7 million, and third-quarter research spending pushed operating expenses above the quarterly pace implied by management's prior full-year plan.
The question now is whether these expanding evaluations will convert into paid licenses before higher equipment lease bills force another stock offering. Either the IQE partnership and gate-all-around tests bring in commercial fees over the next year, or the company continues to fund unpaid testing through share dilution. Electrical test results from the lead gate-all-around customer around year-end will tell.
🐂 Bull Case
IQE Deal Adds a Wafer Manufacturing Partner
Atomera develops Mears Silicon Technology (MST), a thin film that improves how semiconductor transistors handle electricity. Over the past two quarters, management has pitched MST for gallium nitride on silicon (GaN-on-silicon), a material used in radio-frequency chips for mobile networks. Chief executive Scott Bibaud said the company "took an important step toward commercializing our GaN-on-silicon solutions by signing a joint development agreement with IQE, a leading supplier of compound semiconductor wafers."
Under the agreement, the California licensor provides silicon wafers coated with its MST film, and IQE adds the gallium nitride layers. The presentation states that the deal sets up "IQE to manufacture for foundry and IDM customers". This matters because Atomera does not own factories, so partnering with an established wafer supplier gives chipmakers a direct way to buy finished starting wafers rather than changing their own factory lines.
What to watch: paid wafer orders or a licensing agreement from the IQE partnership over the next two to four quarters. Commercial revenue from IQE customers would show that radio-frequency chipmakers are willing to pay for the test improvements management reported last quarter.
Third Leading Chipmaker Joins Gate-All-Around Testing
Gate-all-around (GAA) is the newest transistor architecture used by the world's four leading logic chipmakers to build advanced artificial intelligence processors. Atomera wants these manufacturers to use its MST film to block phosphorus from leaking inside those tiny 3D structures. This quarter, the semiconductor technology firm "Increased engagement count to three customers in gate-all-around", up from two in the first half of the year.
Bibaud also said the company's diffusion-blocking work is drawing interest "not only with the GAA foundries, but also with designers of next generation memory solutions". In dynamic random-access memory (DRAM), the presentation shows that an MST film can eliminate two selective deposition steps and one wafer-bonding step. Adding the third logic manufacturer widens the pool of potential licensees, though testing still takes months per cycle.
What to watch: electrical test results from the first GAA customer that finished physical deposition work last quarter, due around year-end. Positive electrical data without a repeat test cycle would allow that customer to move toward an in-factory research license.
🐻 Bear Case
Revenue Dropped to Zero With No Backlog
Bibaud told investors that "work in our traditional business is taking off" as customer engagements expand across advanced logic and memory chips. Yet the income statement shows that engineering and licensing activity did not produce a single dollar of sales in the third quarter. After collecting $158,000 in the second quarter from wafer deliveries, revenue fell back to zero.
- Third-quarter revenue: $0, down from $158,000 in the second quarter and $11,000 a year ago
- Nine-month revenue: $169,000 across the first three quarters of 2026
- Deferred revenue: $0 at September 30, unchanged from June 30 and down from $144,000 a year ago
The empty revenue line cuts against the claim that the core business is taking off commercially. Deferred revenue — cash customers have paid upfront for wafers or services not yet delivered — also stayed at zero for a second straight quarter. Because the balance sheet holds no unearned customer payments and management gave no fourth-quarter revenue outlook, customer testing remains unpaid or sporadic.
What to watch: deferred revenue and fourth-quarter revenue in the full-year report. A rebound in customer prepayments or engineering billings would show that new partnerships are bringing in cash before a full royalty license arrives.
Equipment Lease Obligations More Than Doubled
Because Atomera had zero revenue in the third quarter, its operating loss equals its total operating expenses of $6.33 million, widened from $5.79 million a year ago. Excluding stock-based compensation and depreciation, operating expenses were $4.57 million, up 5.8% from a year ago. Research and development — the cost of running wafer tests and engineering tools — drove the increase, rising 8.8% excluding one-offs to $3.00 million.
- Operating lease liabilities: $2.73 million total, up 135% from $1.16 million in the second quarter by our math
- Current operating lease liability: $1.91 million, up from $304,000 three months ago
- Implied fourth-quarter operating expenses excluding one-offs: $3.99 million to $4.24 million by our math to meet the prior full-year plan
The balance sheet shows the tool-lease cost jump management warned about last quarter has arrived. Current operating lease obligations rose more than sixfold from June, and third-quarter expenses excluding one-offs beat the $4.16 million to $4.41 million quarterly pace implied by the prior full-year outlook. To stay inside its $18.25 million to $18.75 million full-year range, the company must cut fourth-quarter spending by 7% to 13% from Q3.
What to watch: fourth-quarter operating expenses excluding one-offs against the $4.24 million ceiling implied by the top of the full-year plan. A reading above that figure would confirm that higher equipment lease bills have permanently lifted the quarterly cost base.
Share Count Up 25% as Cash Drains
Atomera funds its research by selling new shares to investors. Following its February stock offering, the weighted average share count reached 38.9 million in the third quarter, up 25.0% from 31.1 million a year ago by our math. That extra share count is the only reason the net loss per share narrowed from $0.17 to $0.15 while the actual net loss widened by 7.8% to $6.01 million.
Cash, cash equivalents and short-term investments fell by $3.52 million during the quarter to $34.8 million, down 9.2% from $38.4 million at the end of June by our math. At the third-quarter cash drain of $3.5 million, the company has roughly ten quarters of cash left, but the jump in current operating lease liabilities to $1.91 million points to heavier cash outflows over the next twelve months.
What to watch: the quarterly cash drain in the fourth quarter and any new sales of common stock under the company's at-the-market offering program. A cash drain above $4.0 million per quarter would shorten the time before management needs to issue shares again.
Risks this quarter didn't answer
Several standing questions around customer testing schedules and commercial terms received no new data in the third-quarter release or presentation.
- Gate-all-around electrical results: no update on whether the lead evaluator's wafers passed electrical testing or require a nine-month repeat cycle.
- Legacy joint development agreements and STMicroelectronics: neither the release nor the slides mention the older JDA partners or the stalled STMicroelectronics program.
- License fee structure: management has still not disclosed the upfront or royalty terms under discussion with any customer.
💲 Other KPIs
Overhead and legal costs fell 26.2% from the second quarter's $3.17 million peak, though they remain up 8.0% from a year ago by our math. Excluding stock-based compensation and depreciation, general and administrative spending dropped 38.9% from last quarter to $1.30 million, reversing the second quarter's legal and bonus cost jump.
Employee stock grants rose 30.1% from $1.34 million a year ago by our math, and edged up from $1.74 million in the second quarter. Stock-based compensation made up 27.6% of total GAAP operating expenses in the third quarter, widening the gap between the $6.01 million GAAP net loss and the $4.57 million adjusted EBITDA loss.
Sales spending fell 21.5% from $437,000 in the second quarter, but sits 65.7% above the $207,000 spent a year ago by our math. The year-over-year rise reflects the hiring of a sales vice president last autumn to pitch licensing deals to chip foundries.
❓ Key Questions
What are the commercial and financial terms with IQE?
The joint development agreement sets up IQE to make GaN-on-silicon wafers for chipmakers, but the release does not say whether either partner pays upfront fees, how development costs are split, or when wafer sales could begin.
Did the lead gate-all-around customer pass electrical testing?
Management said last quarter that physical deposition work cleared a milestone with one evaluator and that electrical results could lead to a license by late 2026, while a repeat test would add nine months.
Why did revenue and deferred revenue both stay at zero?
Atomera expanded gate-all-around engagements from two to three customers and worked on memory and GaN, yet billed zero revenue in Q3 and ended with zero deferred revenue on the balance sheet.
Does the $18.75 million full-year expense plan still hold?
Nine-month operating expenses excluding one-offs reached $14.51 million, and current operating lease liabilities jumped to $1.91 million. Meeting the prior $18.75 million full-year ceiling requires fourth-quarter spending to drop to $4.24 million.